← Back to all trials
Recruiting
NCT05706558
Retrospective Review of Esophageal Cancer at MSKCC
Conditions: Esophageal Cancer, Esophagus Cancer
Sex: All
Ages: 18 Years – N/A
Enrollment: 4000
Sponsor: Memorial Sloan Kettering Cancer Center
Location: United States
Summary
Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial.
In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.
Eligibility Criteria
Inclusion Criteria:Histologically confirmed esophageal adenocarcinoma (EAC) or esophageal squamous cell carcinoma (ESCC) undergoing esophagectomyPathologic staged T3 tumors (pT3)Exclusion Criteria:Pathologic staged T0-2 (pT0-2) or T4 tumors (pT4)Patients with histologic types other than EAC or ESCC, dysplasia or carcinoma in situ without tumor invasion,Patients undergoing salvage esophagectomyEvidence of distant metastatic diseasePatients with a positive proximal or distal margin
Source: ClinicalTrials.gov (NCT05706558). StuddyBuddy aggregates publicly available trial information.